| Literature DB >> 35370647 |
Yuli Zhang1,2, Long Huo3, Zhenzhen Wei1, Qingfeng Tang4,5, Hua Sui1,6.
Abstract
Methods: Articles on inflammatory tumor microenvironment were retrieved from the Web of Science Core Collection, and the characteristics of the articles were analyzed by CiteSpace software. Background: The inflammatory tumor microenvironment is an essential feature of the tumor microenvironment. The way in which it promotes or inhibits tumor progression plays an important role in the outcome of a tumor treatment. This research aims to explore a scientific collaboration network, describe evolution of hotspots, and predict future trends through bibliometric analysis.Entities:
Keywords: CiteSpace; bibliometric; hotspot; inflammatory tumor microenvironment; visualization
Year: 2022 PMID: 35370647 PMCID: PMC8968939 DOI: 10.3389/fphar.2022.862585
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1Distribution of annual publications and citations on inflammatory tumor microenvironment.
FIGURE 2Country/region co-occurrence knowledge map of the inflammatory tumor microenvironment.
Top 12 country/region and institutions related to the inflammatory tumor microenvironment.
| Rank | Country | Year | Centrality | Count(%) | Institution | Year | Centrality | Count(%) |
|---|---|---|---|---|---|---|---|---|
| 1 | United States | 1998 | 0.60 | 1,358 (28.90%) | Univ Texas MD Anderson Cancer Center (United States ) | 2008 | 0.09 | 69 (1.98%) |
| 2 | China | 2006 | 0.10 | 766 (16.30%) | NCI (United States ) | 2000 | 0.09 | 69 (1.98%) |
| 3 | Germany | 2001 | 0.15 | 290 (6.17%) | Univ Pittsburgh (United States ) | 2007 | 0.04 | 66 (1.90%) |
| 4 | Italy | 2000 | 0.16 | 283 (6.02%) | German Cancer Research Center (Germany) | 2011 | 0.27 | 57 (1.64%) |
| 5 | Japan | 2006 | 0.02 | 192 (4.09%) | Sun Yat Sen Univ (China) | 2012 | 0.02 | 52 (1.49%) |
| 6 | France | 2005 | 0.13 | 141 (3.00%) | Huazhong Univ Sci and Technol (China) | 2010 | 0.12 | 47 (1.35%) |
| 7 | England | 2003 | 0.24 | 123 (2.62%) | Univ Pennsylvania (United States ) | 2010 | 0.04 | 47 (1.35%) |
| 8 | South Korea | 2007 | 0.03 | 115 (2.45%) | Univ of California San Diego (United States ) | 2008 | 0.02 | 41 (1.18%) |
| 9 | Brazil | 2009 | 0.03 | 91 (1.94%) | Zhejiang Univ (China) | 2013 | 0.02 | 40 (1.15%) |
| 10 | Canada | 2003 | 0.05 | 89 (1.89%) | Shanghai Jiao Tong Univ (China) | 2014 | 0.06 | 39 (1.12%) |
| 11 | Israel | 2007 | 0.02 | 85 (1.81%) | Johns Hopkins Univ (United States ) | 2008 | 0.34 | 39 (1.12%) |
| 12 | India | 2008 | 0.10 | 79 (1.68%) | Harvard Med Sch (United States ) | 2016 | 0.00 | 39 (1.12%) |
FIGURE 3Institution co-occurrence knowledge map of the inflammatory tumor microenvironment.
FIGURE 4Author co-occurrence knowledge map of the inflammatory tumor microenvironment.
FIGURE 5(A) Co-citation co-occurrence knowledge map of the inflammatory tumor microenvironment. (B) Co-citation clustering knowledge map of the inflammatory tumor microenvironment.
FIGURE 6Timeline view of co-citation clustering knowledge map of the inflammatory tumor microenvironment.
Top 10 co-cited publications and journals on inflammatory tumor microenvironment.
| Rank | Count | Centrality | Publication | Year | Count | Centrality | Journal | JCR |
|---|---|---|---|---|---|---|---|---|
| 1 | 250 | 0.02 | Hallmarks of Cancer: The Next Generation, | 2011 | 2,889 | 0.03 |
| Q1 |
| 2 | 135 | 0.01 | Immunity, Inflammation, and Cancer, | 2010 | 2,540 | 0.02 |
| Q1 |
| 3 | 131 | 0.00 | Global Cancer Statistics 2018 GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, | 2018 | 2,358 | 0.02 |
| Q1 |
| 4 | 123 | 0.02 | Cancer-Related Inflammation, | 2008 | 2,319 | 0.01 |
| Q1 |
| 5 | 91 | 0.02 | Myeloid-Derived Suppressor Cells as Regulators of the Immune System, | 2009 | 2,163 | 0.01 |
| Q1 |
| 6 | 89 | 0.03 | Coordinated Regulation of Myeloid Cells by Tumors, | 2012 | 2,069 | 0.02 |
| Q2 |
| 7 | 81 | 0.04 | Tumor-Associated Macrophages: From Mechanisms to Therapy, | 2014 | 2,051 | 0.01 |
| Q1 |
| 8 | 79 | 0.04 | Recommendations for Myeloid-Derived Suppressor Cell Nomenclature and Characterization Standards, | 2010 | 2,027 | 0.01 |
| Q2 |
| 9 | 79 | 0.03 | Macrophage Diversity Enhances Tumor Progression and Metastasis, | 2016 | 1,948 | 0.01 |
| Q1 |
| 10 | 78 | 0.00 | Cancer Statistics 2019, | 2019 | 1,893 | 0.01 |
| Q1 |
FIGURE 7Keyword co-occurrence knowledge map of the inflammatory tumor microenvironment.
FIGURE 8Top 25 keywords with the strongest citation bursts on inflammatory tumor microenvironment.